<DOC>
	<DOC>NCT03070028</DOC>
	<brief_summary>Patients with pilonidal sinus disease will be randomised to two groups (crystallised phenol and platelet rich plasma). Sinus healing time, patient satisfaction, complications and recurrence rates will be compared.</brief_summary>
	<brief_title>Minimally Invasive Treatment Methods for Pilonidal Disease</brief_title>
	<detailed_description>Patients with pilonidal sinus disease will be treated by either crystallised phenol or platelet rich plasma application. Treatment results, healing time, postprocedural complications, patient satisfaction and recurrences will be compared.</detailed_description>
	<mesh_term>Pilonidal Sinus</mesh_term>
	<mesh_term>Phenol</mesh_term>
	<criteria>Having pilonidal sinus disease accepting to be involved in the study below the age of 18 having connective tissue disorders diabetes mellitus severe anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>